We noticed that PiHL activation could repress cell apoptosis induced by 5-FU in both p53 wild-type and knockout CRC cells, prompting us to further explore PiHL’s potential role in drug resistance and its mechanisms other than p53 regulation. This evidence concerns the gene TP53 and colorectal carcinoma.